Gene · 56914
OTOR: otoraplin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. OTOR: otoraplin. Genes, record 56914. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/56914
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NRC9 | Otoraplin | 128 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents104
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 56690 | Q9NRC9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1182 | Q9NRC9 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9880 | Q9NRC9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7246 | Q9NRC9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7246 | Q9NRC9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1182 | Q9NRC9 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 9880 | Q9NRC9 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 9880 | Q9NRC9 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 9887 | Q9NRC9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 60478 | Q9NRC9 | Espacenet |
1 to 10 of 104
See all 104 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants203
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | OTOR papers | Newest fiscal year |
|---|---|---|---|
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 2 | 2025 |
| T32ES007015 | Molecular & Environmental Toxicology Predoctoral Training Program | 2 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 1 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 1 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 1 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 1 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 1 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 1 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 1 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 1 | 2025 |
1 to 10 of 203Source NIH's project files
See all 203 nih grantsPapers1,445
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome. | Front Med (Lausanne) | 2026 | 42755913 | PubTator, text mining | PubMed |
| Fibrin Degradation Products Regulate Endothelial Barrier Function in Traumatic Brain Injury via the Actin Cytoskeleton. | Neurotrauma Rep | 2026 | 42666666 | PubTator, text mining | PubMed |
| Fibrin degradation products enhance plasmin activity and contribute to fibrinolysis during simulated trauma-induced coagulopathy. | Blood Coagul Fibrinolysis | 2026 | 42083375 | PubTator, text mining | PubMed |
| Analyzing Misinformation and Disinformation: Understanding Swiss COVID-19 Narratives Through Natural Language Processing Analysis. | JMIR Infodemiology | 2026 | 41911325 | PubTator, text mining | PubMed |
| Flexor Tendon Repair Using a New Looped Six- and Eight-Strand Technique-A Biomechanical Analysis. | J Pers Med | 2026 | 41893012 | PubTator, text mining | PubMed |
| Fibrinogen-Bmal1 signaling as a therapeutic target to limit aortic dissection by preserving VSMC contractility. | Signal Transduct Target Ther | 2026 | 41856973 | PubTator, text mining | PubMed |
| Analysis of clinical features of AECOPD at different altitudes and GOLD stages in high-altitude regions. | BMJ Open Respir Res | 2026 | 41825891 | PubTator, text mining | PubMed |
| Establishment of Age-Specific Reference Intervals for 16 Coagulation Parameters in Chinese Children Using Sysmex CN-6000 Analyzer: A Cross-Sectional Study. | Health Sci Rep | 2026 | 41822764 | PubTator, text mining | PubMed |
| Preparation of Felodipine-PEG Solid Dispersions by Solvent-Free scCO2 Processing and Their Translation into Orally Disintegrating Tablets. | ACS Omega | 2026 | 41768666 | PubTator, text mining | PubMed |
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report. | Cancer Rep (Hoboken) | 2026 | 41761754 | PubTator, text mining | PubMed |
1 to 10 of 1,445
See all 1,445 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/56914
GET https://conductscience.org/api/genes/v1/56914/patents?page=2